0001209191-20-047842.txt : 20200820
0001209191-20-047842.hdr.sgml : 20200820
20200820201721
ACCESSION NUMBER: 0001209191-20-047842
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200818
FILED AS OF DATE: 20200820
DATE AS OF CHANGE: 20200820
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Thomas Dolca
CENTRAL INDEX KEY: 0001768239
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38653
FILM NUMBER: 201121276
MAIL ADDRESS:
STREET 1: C/O PRINCIPIA BIOPHARMA INC.
STREET 2: 220 E. GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Principia Biopharma Inc.
CENTRAL INDEX KEY: 0001510487
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263487603
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 220 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 416-7700
MAIL ADDRESS:
STREET 1: 220 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-08-18
0
0001510487
Principia Biopharma Inc.
PRNB
0001768239
Thomas Dolca
C/O PRINCIPIA BIOPHARMA INC.
220 E. GRAND AVENUE
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Medical Officer
Common Stock
2020-08-18
4
M
0
15000
23.77
A
16826
D
Common Stock
2020-08-18
4
S
0
15000
100.00
D
1826
D
Employee Stock Option (right to buy)
23.77
2020-08-18
4
M
0
15000
0.00
D
2028-10-22
Common Stock
15000
168057
D
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The stock option vested and became exercisable as to 25% of the shares subject to the option on October 22, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
/s/ Christopher Y. Chai, Attorney-in-Fact for Dolca Thomas
2020-08-20